Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic Arthritis

NCT01557452 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped Previous study DSC/08/2357/36 did not show efficacy for Givinostat in JIA. Sponsor decision to stop development of Givinostat in polyarticular course Juvenile Idiopathic Arthritis wasn't related to any tolerability concerns.

Conditions

Interventions

Sponsor

Italfarmaco

Collaborators